Open/Aftercare Treatment for Participants Diagnosed With Obsessive Compulsive Disorder

NCT03511534 | Active Not Recruiting

• 1 other identifier: 41165
• Study Type: interventional
• Target: 200
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to provide participants diagnosed with obsessive compulsive disorder (OCD) and completed one of the active study protocols at the Rodriguez Lab, with open/aftercare treatment.

Conditions

OCD

Keywords

treatment, psychotherapy, pharmacotherapy

Outcome Measures

Primary Outcomes (1)

• Improvement in the severity of OCD symptoms as measured by the Yale-Brown Obsessive Compulsive Scale (YBOCS)

  Improvement in OCD severity is measured by the YBOCS (Yale Brown Obsessive-Compulsive Scale), a gold standard measure of obsessions and compulsions. For the YBOCS the minimum units are 0 and Maximum units on the total scale are 40. The higher the number on the YBOCS, the more severe the symptoms. Response is defined as at least a 35% reduction on the YBOCS.

  Up to 14 weeks

Study Arms (2)

Psychotherapy

ACTIVE COMPARATOR

Participants will receive evidenced based psychotherapy by a trained psychologist

Behavioral: Psychotherapy

Pharmacotherapy

ACTIVE COMPARATOR

Participants will receive pharmacotherapy by a psychiatrist

Other: Pharmacotherapy

Interventions

Psychotherapy BEHAVIORAL

Evidenced based psychotherapy by a trained psychologist

Psychotherapy

Pharmacotherapy OTHER

Pharmacotherapy by a psychiatrist

Pharmacotherapy

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Ability to speak and understand English
• Capacity to consent (e.g. as determined by assessing the patient's understanding of the risks, benefits, and procedures of the study)
• Completed an active study protocol at the Rodriguez Lab at Stanford University

You may not qualify if:

• Children younger than 18
• Active suicidality

Sponsors & Collaborators

• Stanford University: lead

Study Sites (1)

Stanford University

Stanford, California, 94305, United States

Location

MeSH Terms

Interventions

Psychotherapy; Drug Therapy

Intervention Hierarchy (Ancestors)

Behavioral Disciplines and Activities; Therapeutics

Study Officials

• Carolyn Rodriguez, MD, PhD

  Assistant Professor, Stanford University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NON RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant Professor

Model Details: Participants will choose to enter the psychotherapy or pharmacotherapy arm.

Study Record Dates

• First Submitted: April 18, 2018
• First Posted: April 30, 2018
• Study Start: June 23, 2017
• Primary Completion (Estimated): June 1, 2026
• Study Completion (Estimated): June 1, 2026
• Last Updated: July 16, 2025

Record last verified: 2025-07

Locations

US (1)